Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa.
Dorina OnoyaKamban HirasenLiudmyla van den BergJacqui MiotLawrence C LongMatthew P FoxPublished in: Drug safety (2019)
The rates of AEs were lowest among patients receiving a TDF-based second-line regimen. Patients with poorer health at the time of switch were at higher risk of AEs when receiving second-line ART and may require closer monitoring to improve the durability of second-line therapy.
Keyphrases
- adverse drug
- antiretroviral therapy
- hiv positive
- south africa
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- hiv aids
- healthcare
- public health
- electronic health record
- mental health
- emergency department
- health information
- mesenchymal stem cells
- men who have sex with men
- hepatitis c virus
- bone marrow